These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 15877740

  • 21. Splenectomy in patients with mixed myelodysplastic/myeloproliferative disease.
    Kraemer D, Rüdiger T, Reimer P, Müller-Hermelink HK, Wilhelm M.
    Ann Hematol; 2002 Jun; 81(6):308-11. PubMed ID: 12107559
    [Abstract] [Full Text] [Related]

  • 22. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
    Emiliani C, Ciferri S, Mencarelli S, Mezzasoma AM, Momi S, Orlacchio A, Gresele P.
    Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
    [Abstract] [Full Text] [Related]

  • 23. High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.
    Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G, AGIMM Investigators.
    PLoS One; 2010 Dec 09; 5(12):e15277. PubMed ID: 21151606
    [Abstract] [Full Text] [Related]

  • 24. The role of thrombophilia in splanchnic vein thrombosis.
    Primignani M, Mannucci PM.
    Semin Liver Dis; 2008 Aug 09; 28(3):293-301. PubMed ID: 18814082
    [Abstract] [Full Text] [Related]

  • 25. Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies.
    Kiladjian JJ, Cassinat B.
    Am J Hematol; 2023 May 09; 98(5):794-800. PubMed ID: 36869873
    [Abstract] [Full Text] [Related]

  • 26. Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach.
    Thiele J, Kvasnicka HM, Orazi A.
    Semin Hematol; 2005 Oct 09; 42(4):184-95. PubMed ID: 16210032
    [Abstract] [Full Text] [Related]

  • 27. A simplified endogenous erythroid colony assay for the investigation of polycythaemia.
    Tey SK, Cobcroft R, Grimmett K, Marlton P, Gill D, Mills A.
    Clin Lab Haematol; 2004 Apr 09; 26(2):115-21. PubMed ID: 15053805
    [Abstract] [Full Text] [Related]

  • 28. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A.
    Pathobiology; 2007 Apr 09; 74(2):97-114. PubMed ID: 17587881
    [Abstract] [Full Text] [Related]

  • 29. Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.
    Lavu S, Szuber N, Mudireddy M, Yogarajah M, Gangat N, Pardanani A, Hanson CA, Ketterling RP, Ashrani AA, Kamath PS, Tefferi A.
    Am J Hematol; 2018 Mar 09; 93(3):E61-E64. PubMed ID: 29194707
    [No Abstract] [Full Text] [Related]

  • 30. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM.
    Minerva Cardioangiol; 2007 Dec 09; 55(6):741-53. PubMed ID: 18091643
    [Abstract] [Full Text] [Related]

  • 31. [Any splanchnic vein thrombosis must make look for a forme fruste of myeloproliferative disorder].
    Casadevall N, Valla D.
    Rev Prat; 2005 Oct 15; 55(15):1669-70. PubMed ID: 16334203
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A retrospective analysis of patients treated for superficial vein thrombosis.
    Wichers IM, Haighton M, Büller HR, Middeldorp S.
    Neth J Med; 2008 Nov 15; 66(10):423-7. PubMed ID: 19011268
    [Abstract] [Full Text] [Related]

  • 34. Classification of Ph-negative chronic myeloproliferative disorders--morphology as the yardstick of classification.
    Kvasnicka HM, Thiele J.
    Pathobiology; 2007 Nov 15; 74(2):63-71. PubMed ID: 17587877
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.
    Mercier F, Monczak Y, François M, Prchal J, Galipeau J.
    Exp Hematol; 2009 Mar 15; 37(3):416-20. PubMed ID: 19135773
    [Abstract] [Full Text] [Related]

  • 40. Recurrent venous thrombosis: the sole manifestation of an occult myeloproliferative disease.
    Lang R, Inbal A, Jutrin I, Ravid M.
    Isr J Med Sci; 1982 Jun 15; 18(6):705-7. PubMed ID: 7107208
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.